Stephen P. Carey, senior vice president and chief financial officer of ANI Pharmaceuticals Inc. (NASDAQ:ANIP), sold 2,850 shares of common stock on October 29, 2026, for a total value of $207,679, according to the source. The shares sold at prices ranging from $72.18 to $73.29.
The source says the sale was made under a Rule 10b5-1 trading plan that Carey adopted on March 6, 2026. After the sale, Carey directly owns 166,143 shares, the source reports.
The source also reports that ANI Pharmaceuticals posted stronger-than-expected second-quarter 2026 results, with adjusted earnings of $2.21 per share against an estimate of $2.03, and record revenue of $266 million against a forecast of $262.14 million. The company cut its full-year 2026 guidance for Cortrophin Gel by $20 million to $25 million, citing weak first-half performance, but still expects 50% to 55% year-over-year growth for the product.
Guggenheim kept a Buy rating and lowered its price target from $124 to $119. Canaccord Genuity lowered its target to $90 from $91. Oppenheimer initiated coverage with a Perform rating and an $85 target.